CAUTION: We have been advised that fraudulent emails with a modified domain name have been sent by a source purporting to be from Aird & Berlis LLP. These communications are not legitimate and are not from Aird & Berlis LLP. Disregard any such emails and do not engage with the sender or the email in any way. Please report the attempted fraud by contacting the Canadian Anti-Fraud Centre and by emailing Aird & Berlis LLP at help@airdberlis.com.

Back to all Representative Matters
Feb 19, 2021

PsyBio Completes Reverse Takeover and $14.5 Million Private Placement

Sherri M. Altshuler, Melanie Cole, Adria Leung Lim, Amy Marcen-Gaudaur, Russell J. Sanders, Meredith McCann and Barbara Worndl

PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (“PsyBio”) recently completed a reverse takeover (the “Reverse Takeover”) of PsyBio Therapeutics, Inc. (the “Target”), a biotechnology company developing a new class of drugs intended for the potential treatment of mental health challenges and other disorders.

The Reverse Takeover was completed by way of a “three-cornered” amalgamation pursuant to the provisions of the Business Corporations Act (British Columbia) and a “three-cornered” merger under the laws of the State of Delaware. The Reverse Takeover constitutes PsyBio’s Qualifying Transaction (as defined by Policy 2.4 of the TSX Venture Exchange (the “TSXV”).

In connection with the Reverse Takeover, on December 4, 2020, PsyBio Therapeutics Financing Inc. (“Finco”), a special purpose financing entity, completed a brokered private placement of 41,409,698 subscription receipts (“Subscription Receipts”) at a price of $0.35 per Subscription Receipt for aggregate gross proceeds of approximately $14.5 million. The Subscription Receipts were converted into shares of Finco and exchanged for subordinate voting shares of PsyBio (“Subordinate Voting Shares”) on closing of the Reverse Takeover.

The Subordinate Voting Shares commenced trading on the TSXV under the symbol “PSYB” on February 25, 2021.  

Aird & Berlis represented the Target with a team that included Sherri Altshuler, Melanie Cole, Adria Leung Lim, Amy Marcen-Gaudaur, Russell Sanders, Meredith McCann, David Mba (Corporate and Securities) and Barbara Worndl (Tax).

Related Representative Matters

Representative Matters
Shareholders of Suncoast Seafood Inc. and Raymond O’Neill & Son Fisheries Ltd. Complete $110 Million Sale Joel M. Rose, Jeremy D. Burke, Jesse Rosensweet, Joanne C. Coldwell, Barbara Worndl, Sarah Newman, Jessie Lewis and Emily Chittick Oct 26, 2021 Aird & Berlis advised the shareholders of Suncoast Seafood Inc. and Raymond O’Neill & Son Fisheri... Aird & Berlis advised the shareholders of Suncoast Seafood Inc. and Raymond O’Neill & Son Fisheries Ltd.
Representative Matters
Putman Investments Acquires Toys “R” Us Canada Tony Gioia, Graham Topa, Francesco Gucciardo, Barbara Worndl, Aarondeep (Aaron) S. Bains, Stephen Zolf, R. Grant Cansfield and Lynn Tay Aug 30, 2021 On August 19, 2021, Putman Investments Inc., a Canadian-based, family-owned enterprise, announced... On August 19, 2021, Putman Investments Inc., a Canadian-based, family-owned enterprise, announced its acquisition of Toys “R” Us and Babies “R” Us Canada from Fairfax Financial Holdings Limited. Toys “R” Us, a household name in children’s toys, has 81 loc...
Representative Matters
goeasy Ltd. Acquires LendCare for $320 Million Donald L. West, Jill P. Fraser, David Malach and Barbara Worndl May 04, 2021 On April 30, 2021, goeasy Ltd. (TSX: GSY), a full-service provider of goods and alternative finan... On April 30, 2021, goeasy Ltd. (TSX: GSY), a full-service provider of goods and alternative financial services, completed its acquisition of LendCare Holdings Inc., a Canadian point-of-sale consumer finance and technology company, from LendCare’s founders and CIVC Partners for $320 million